HOLD at $325.42: Converged thesis maintains 2-3% ceiling while structural quality and valuation/momentum divergence require active execution framework
HOLD is dispositive across all five voices: structural franchise quality (48% ROE, 20.6% operating margins, $7-9B FCF, $210B backlog) prevents Underweight/Sell while broken momentum (below 10 EMA, 50 SMA downtrend, MACD histogram re-widening to -2.10, RSI retest failure) and stretched valuation (38x P/E, 4.31x PEG) preclude Buy/Overweight. The prior decision chain validates this: 9/3 Hold at $331 produced +1.5% alpha, 9/2 Hold at $329.50 produced +0.2% alpha, while 9/8 Underweight at $334 produced -2.4% alpha with the reflection explicitly noting "sizing underweight trims at 25-30% on quality compounders near ATH multiples should be treated primarily as portfolio-risk reduction with alpha as a secondary, capped bonus." The $280 cost basis with $318.06 as profit-protection stop is operationally consistent — the position is already profitable. Rating remains HOLD with explicit re-triggers at $318.06 stop, $336.60 add trigger, $347-355 trim zone, $300 hard invalidation, 10-session time-based reassessment, and Q3 2026 earnings print. Price target 385.0.
| Position | Action |
|---|---|
| At $325.42 with 38x P/E and broken momentum | Hold core position at 2-3% portfolio ceiling, no fresh capital deployment |
| Price reaches $347-355 zone (Bollinger middle / 50 SMA) | Trim 10-15% ONLY on failed reclaim (RSI <50, MACD histogram still negative, no volume confirmation) |
| Daily close below $318.06 on expanding volume | Reassess to Underweight with 25-30% trim intent |
| Weekly close below $300 on rising ATR >$9 | Reassess to Sell with intent to exit remaining exposure |
| Macro: Brent crude moves >$110 or 10-year yield pushes above current levels | Position-size reassessment regardless of technicals |
The "HOLD" verdict is too cautious because the structural fundamentals—48% ROE, 20%+ growth, fortress balance sheet, strategic CPP acquisition precluding SpaceX, and emerging AI rotation into aerospace—create asymmetric upside to $400-420 versus limited downside to $260-280.
| Indicator | Value | Signal |
|---|---|---|
| Close | 325.42 | neutral |
| Open | 330.88 | neutral |
| High | 332.06 | neutral |
| Low | 321.16 | neutral |
| Volume | 5,002,849 | bearish |
| 10 EMA | 336.60 | bearish |
| 50 SMA | 355.54 | bearish |
| 200 SMA | 321.14 | neutral |
| RSI | 35.56 | bearish |
| MACD Line | -7.68 | bearish |
| MACD Signal | -5.58 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Constructive basing pattern establishing higher low above $321 with MACD histogram contraction and RSI sustained >40
Then: Add on constructive basing pattern
↩ rebuts: “Bear's framing of CPP as 'four quarters of cash flow for one chokepoint' being expensive”
EV: +$23-29% to $400-420 · concedes: Two-quarter cash flow compression from CPP integration is real but is a digestion event, not structural impairment; A close above $336.60 on volume would be an ideal entry trigger; RSI at 35.56 with no bullish divergence yet means the reversal candle has not yet printed; The bear is correct on entry triggers (wait for confirmation above $336.60) but wrong on the thesis
GE Aerospace's strong fundamentals are priced for perfection at a 38x P/E, 4.31 PEG, and 19x P/B with no margin of safety, while technical momentum is deteriorating (MACD reaccelerating lower, 50 SMA rolled over, RSI failed retest) and the $11.75B CPP acquisition introduces cycle-peak M&A risk that could compress multiples and FCF simultaneously if any thesis leg fails.
EV: $260-280 (bear case); $400-420 (bull case, requiring five conditions) · concedes: Defense exposure is real and growing; CPP does provide some supply chain integration; Current fundamentals (21% revenue growth) are excellent; LEAP engine cycle has multi-year runway; GE management team is improved from legacy
→ vs conservative: Claims momentum is 'broken' and there is 'zero margin of safety'—too absolute; weak momentum is not broken long-term value when price holds above 200 SMA
→ vs conservative: The $280 entry price paired with $318.06 stop is structurally flawed (stop above entry); $318.06 is better interpreted as profit-protection level for existing position rather than new-entry stop
→ vs neutral: Using P/E, PEG, and P/B mechanically overstates risk; book value is distorted by $91B treasury stock against only $17.84B common equity
→ vs neutral: Waiting for $300-$310 or $280-$300 is more conservative than necessary; waiting for full 7.8-14% drawdown before adding is a classic error when near major support
→ vs neutral: Concern about aerospace cycle underweights high-margin aftermarket and service exposure providing durability through cycles
| MACD Histogram | -2.10 | bearish |
| Bollinger Upper | 376.58 | neutral |
| Bollinger Middle | 347.32 | neutral |
| Bollinger Lower | 318.06 | neutral |
| ATR | 8.91 | neutral |
| Rating | HOLD | neutral |
Support: 321.14 · 318.06 | Resistance: 336.6 · 347.32 · 355.54
GE Aerospace is in a confirmed short-term downtrend with price below the 10 EMA (336.60) and 50 SMA (355.54), holding marginally above the critical 200 SMA support at 321.14 by only 1.3%. Technical indicators are uniformly bearish: RSI at 35.56 is approaching oversold territory, MACD at -7.68 with histogram re-widening shows momentum reaccelerating downward, and ATR has contracted to 8.91 suggesting selling may be exhausting. The report recommends HOLD with active risk management, as a close below 318.06 would confirm major breakdown while a close above 336.60 on volume >4M would signal a tactical bounce entry opportunity.
Market Cap
$337.6B
Beta
1.35
P/E (TTM)
38.4x
Forward P/E
35.8x
PEG Ratio
4.31
Price / Book
19.1x
EPS (TTM)
$8.47
Forward EPS
$9.09
Dividend Yield
0.56%
52-Week High
$388.84
52-Week Low
$268.91
Revenue (TTM)
$50.64B
Gross Margin
31.1%
EBITDA Margin
22.7%
Net Margin
17.7%
Operating Margin
20.6%
ROE
48.2%
ROA
5.1%
Total Assets
$127.67B
Total Equity
$17.84B
Total Debt
$19.16B
Cash & Equivalents
$9.35B
Net Debt / EBITDA
~0.85x
Debt / Equity
113%
Current Ratio
0.98
Treasury Stock
$91.45B
Book Value Per Share
$17.00
2025 Revenue
$45.855B
2024 Revenue
$38.702B
2023 Revenue
$35.348B
2022 Revenue
$29.139B
2025 Gross Margin
31.5%
2025 Operating Margin
18.9%
2025 Net Income
$8.704B
2025 Diluted EPS
$8.14
2022 Diluted EPS
$0.05
Q2 2026 Revenue
$13.35B
Q2 2026 Operating Income
$2.560B
Q2 2026 Net Income
$2.370B
Q2 2026 Diluted EPS
$2.26
Q2 2026 YoY Revenue Growth
+21.1%
Q2 2026 YoY Operating Income Growth
+22.0%
Q2 2026 YoY EPS Growth
+19.6%
2025 Free Cash Flow
$7.264B
2025 FCF Margin
15.8%
2025 Operating Cash Flow
$8.537B
2025 CapEx
-$1.273B
2025 Buybacks
-$7.551B
2025 Dividends Paid
-$1.452B
Q2 2026 FCF
$2.86B
Annualized TTM FCF
~$8.5-9B
Capital Return (Last 4 Quarters)
$8.36B
Q2 2026 Buyback
$2.13B
Q1 2026 Buyback
$2.40B
Share Count Reduction
~2.4%
Non-Current Deferred Revenue
~$18.1B
Other Non-Current Liabilities
~$43.5B
Goodwill / Intangibles
$13B+
Q2 2026 R&D
$460M
Q2 2026 R&D YoY Growth
+22%
Q2 2025 Operating Margin
19.0%
Q2 2026 Operating Margin
19.2%
2023 Net Income (inflated)
$9.482B
2023 Underlying Net Income
~$5.2B
2023 EBITDA (inflated)
$12.649B
Strengths
Concerns
HOLD
Macro: Mixed macro backdrop with geopolitical tensions driving energy prices higher while central bank easing expectations collapse. Brent crude above $101/bbl due to Iran-Israel conflict escalation creates a dual effect: near-term demand headwind for commercial aviation customers but tailwind for defense budgets and aftermarket services. Fed rate-cut odds near zero (0% September, 6% December per Polymarket) and rising Treasury yields despite tripled buyback program create headwinds for high-multiple equities. Low US recession probability (8%) supports stable industrial demand, while industrial policy stance (US government taking stakes in Anduril 18%, Rigetti 98%) provides defense-sector tailwind. AI-rotation trade (aerospace as alternative to AI names) cited as potential bullish catalyst by Cramer and Barron's.